%0 Journal Article
%T Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy
%A Malcolm D. Mattes
%A Maliha Zainib
%A Manuj Agarwal
%A Sean M. Parker
%J Archive of "Advances in Radiation Oncology".
%D 2018
%R 10.1016/j.adro.2018.04.015
%X Radiation therapy (RT) and nivolumab are standard therapies for a wide range of advanced and metastatic cancers, yet little is known about the toxicity profile of their combined treatment. The rate of grade ¡Ý3 toxicities from nivolumab monotherapy and radiation-only palliative treatments has been reported at 10% to 18% and 0% to 26%, respectively. We reviewed our experience to assess the acute toxicity profile of concurrent RT-nivolumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128090/